Montpellier PUI's success stories
The Pôle Universitaire d'Innovation de Montpellier presents its success stories!

The SICLE.e industrial chair is developing a silicon-based leather tanning process.
Supported and awarded by the Pôle universitaire d'innovation (PUI), it has received funding from theANR under the Chaires industrielles call for projects.

The result of collaboration between researchers at the Institut Charles Gerhardt de Montpellier (ICGM) and the Saint-Gobainthe Pheno-recycle project has led to the development of novel processes for recycling phenolic resin.
A project supported by the Pôle Universitaire d'innovation de Montpellier.

The fruit of a collaboration between theInstitut de Génomique Fonctionnelle (IGF) and theInstitut Pasteur, Neurobiomics is banking on intestinal microbiota to develop a drug that could improve memory.
An innovative project supported by the Pôle Universitaire d'Innovation de Montpellier.

Created within theUMR Eco&Sols, Scanorhizea buried optical sensor developed by Christophe Jourdan (CIRAD) and William Arditi, continuously monitors root growth to assess the impact of fertilizers, irrigation or drought, paving the way for more sustainable agriculture.
A project supported and rewarded by the Pôle Universitaire d'Innovation de Montpellier.

Supported and rewarded by Montpellier's Pôle Universitaire d'Innovation (PUI), Crusoédeveloped by Claude Grison( ChimEco laboratory), is a 100% natural, biosourced tiger mosquito repellent, inspired by the language of nature and respectful of the environment.


Created in 2024 by Clélia Oliva, Terratis produces sterilized mosquitoes to reduceAedes albopictus.
Supported by the Initium incubator and the Pôle Universitaire d'Innovation de Montpellier, the start-up will open a pilot biofactory in 2026 and an industrial site by 2028 to increase production.

Winner of the Booster Innovation Montpellier (BIM), Sarah Colombani, research engineer at the PhyMedExp laboratory, is leading the project OcciCal Therapeuticsproject, a start-up fromInserm, CNRS and theUniversity of Montpellier, aimed at developing an innovative treatment for a common respiratory disorder in hospitals.